Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | NSD2 | O96028 | 3/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
| ▸ | APAF1 | O14727 | 2/20 | 0.32 |
| ▸ | TDP2 | O95551 | 2/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triaziquone SCHEMBL503952 | 0.98 | TP53 (0.38) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL10720448 | 0.91 | TP53 (0.34) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL11350903 | 0.88 | HTT (0.42) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL8974524 | 0.88 | MAPT (0.42) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL7117809 | 0.88 | MAPT (0.44) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL1546343 | 0.86 | MAPT (0.41) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL6387848 | 0.86 | MAPT (0.41) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL1157120 | 0.86 | MAPT (0.36) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL7783197 | 0.86 | MAPT (0.46) | MAPTHTTTP53STAT3SMN1; SMN2 | |
| Triaziquone SCHEMBL9865090 | 0.84 | TP53 (0.36) | MAPTHTTTP53STAT3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4656181-A1 | GLP-1 COMPOSITIONS AND PREPARATION METHOD | Galenicum Health S.L.U. (ES) | 2025-12-03 | — | — | EP | claimed |
| EP-4387590-A2 | PHARMACEUTICAL COMPOSITION COMPRISING NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS | Topas Therapeutics GmbH (DE) | 2024-06-26 | — | — | EP | claimed |
| WO-2023021098-A2 | PHARMACEUTICAL COMPOSITION COMPRISING NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS | TOPAS THERAPEUTICS GMBH (DE) | 2023-02-23 | — | — | WO | claimed |
| EP-2516448-B1 | AMINE SALTS OF CEFDINIR | BILGIC MAHMUT (TR) | 2015-04-15 | — | — | EP | claimed |
| WO-2005059534-A1 | REFILLABLE MICROPROBE | JUSTUS-LIEBIG-UNIVERSITÄT GIESSEN (DE) | 2005-06-30 | — | — | WO | claimed |
| EP-0861340-B1 | PROCESS FOR BINDING FIBROUS WEB | CAMELOT SUPERABSORBENTS LTD (CA) | 2001-04-25 | — | — | EP | claimed |
| EP-0753142-B1 | System for gel electrophoresis | NOVEX (US) | 1999-08-11 | — | — | EP | claimed |
| EP-0585804-B1 | Corn remover containing NaOH | SALTRATES INTERNATIONAL S A (CH) | 1998-10-14 | — | — | EP | claimed |
| US-5597560-A | NON-STEROID ANTIINFLAMMATORY AGENT AND ANTIBIOTIC MIXTURE; SHELF LIFE | LABORATORIOS CUSI, S.A. (ES) | 1997-01-28 | — | — | US | claimed |
| EP-0523046-A1 | 2-ANILINO PHENYLACETIC ACID DERIVATIVES AS INHIBITORS OF PLA 2? AND LIPOXYGENASE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-01-20 | — | — | EP | claimed |
| WO-1991006539-A1 | 2-ANILINO PHENYLACETIC ACID DERIVATIVES AS INHIBITORS OF PLA2 AND LIPOXYGENASE | AMERICAN HOME PRODUCTS CORPORATION (US) | 1991-05-16 | — | — | WO | claimed |
| EP-0417501-A1 | Extra mild shower gel and hair-shampoo formulation with low surfactant concentration | Joh. A. Benckiser GmbH (DE) | 1991-03-20 | — | — | EP | claimed |
| EP-0049475-B1 | SOLUBLE STABILIZED ENZYMES | Modrovich, Ivan Endre (US) | 1986-11-05 | — | — | EP | claimed |
| EP-0094366-B1 | THERMAL ENERGY STORAGE SYSTEM | Monsanto Company (US) | 1986-05-28 | — | — | EP | claimed |
| EP-0034213-B1 | A STABILIZED AQUEOUS COENZYME SOLUTION FOR USE IN A CLINICAL ASSAY, A METHOD OF STABILIZING A LABILE COENZYME IN AN AQUEOUS CLINICAL ASSAY SOLUTION AND A KIT FOR USE IN SAID CLINICAL ASSAY | Modrovich, Ivan Endre (US) | 1984-11-07 | — | — | EP | claimed |
| EP-0034778-B1 | HETERO-IMINO-PROSTACYCLINS AND PROCESS FOR THEIR PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-04-25 | — | — | EP | claimed |
| US-20260000783-A1 | ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW | SAPREME TECHNOLOGIES B.V. (NL) | 2026-01-01 | — | — | US | disclosed |
| EP-4656181-A1 | GLP-1 COMPOSITIONS AND PREPARATION METHOD | Galenicum Health S.L.U. (ES) | 2025-12-03 | — | — | EP | disclosed |
| EP-0029893-A2 | Process for concentration of tumor-inhibiting substances | Theurer, Karl, Prof. Dr. (DE) | 1981-06-10 | — | — | EP | disclosed |
| US-4083957-A | SEPARATION OF SPERM, ELECTROSTATICS | LANG JOHN L | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000783-A1 | ANTIBODY-DRUG CONJUGATE WITH IMPROVED THERAPEUTIC WINDOW | EPCAM, CD47, FCGR3B | MAPT 3753/4885HTT 4725/4885TP53 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.